Monday
09:00 - 15:30
Ochoa Hall

Diabetes journey: Innovative solutions for individual needs

Jay Skyler, Leigh Perreault
Welcome and introduction
Mark Cooper
Understanding diabetes pathophysiology and the mechanism of diabetic complications

Selecting insulin options to meet patients’ needs

Leigh Perreault
Session introduction
Pratik Choudhary
Updates and advantages of second-generation basal insulin analogs
Alice Cheng
Renal function and glucose control with basal insulins
Kamlesh Khunti
Real-life relevance of second-generation basal insulin analogs in high-risk patients
Audience Q&A

Beyond HbA1c: Individualizing treatment with adjunct therapy and technology

Jay Skyler
Session introduction
Jeremy Pettus
Driving innovation in T1D with dual SGLT-1 and -2 inhibition
Thomas Danne
Beyond HbA1c: Measuring the impact of adjunct therapy on the new metrics of control
Audience Q&A
Lunch

Personalizing outcomes: Optimizing treatment options across the patient spectrum

Jay Skyler
Session introduction
Leigh Perreault
Personalizing injectable treatments in T2D
Julio Rosenstock
Emerging strategies to advance GLP-1 receptor agonist therapies in T2D
Jose-Luis Zamorano
Dyslipidemia and diabetes: Personalizing treatment to address CV risk
Helen Colhoun
Targeting the right patient: Improving outcomes with PCSK9 inhibitors
Audience Q&A

Looking at the big picture: Advances in patient care

Leigh Perreault
Session introduction
Jay Skyler
Beta-cell replacement therapy: Hope for the future
Diabetes. Your Type.
Jay Skyler, Leigh Perreault
Close and wrap-up
Symposium by: